Operating Lease, Right-of-Use Asset of LEXICON PHARMACEUTICALS, INC. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LEXICON PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • LEXICON PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,508,000, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,508,000 +$2,497,000 +50% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,456,000 -$731,000 -14% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $4,646,000 -$712,000 -13% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $4,832,000 -$692,000 -13% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $5,011,000 -$676,000 -12% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $5,187,000 -$1,113,000 -18% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $5,358,000 -$1,042,000 -16% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $5,524,000 -$883,000 -14% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $5,687,000 -$1,413,000 -20% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $6,300,000 +$4,500,000 +250% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $6,400,000 +$4,300,000 +205% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $6,407,000 +$4,107,000 +179% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $7,100,000 +$4,600,000 +184% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,800,000 -$900,000 -33% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $2,100,000 -$800,000 -28% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $2,300,000 +$2,300,000 31 Dec 2021 10-K 03 Mar 2023 2019 FY
Q3 2021 $2,500,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $2,700,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $2,900,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $0 -$1,799,000 -100% 31 Dec 2020 10-K 03 Mar 2023 2019 FY
Q4 2019 $1,799,000 -$301,000 -14% 31 Dec 2019 10-K 10 Mar 2022 2019 FY
Q3 2019 $1,800,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $1,900,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $2,000,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $2,100,000 01 Jan 2019 10-Q 07 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.